Sustained fracture risk reduction over 5 years with risedronate therapy

Watts, NB; Brown, J; Hosking, D; Adami, S; Mulder, H; Reginster, Jean-Yves; Kasibhatla, C; Chines, A

Request a copy

Paper published in a journal (Scientific congresses and symposiums)

Sustained fracture risk reduction over 5 years with risedronate therapy

Watts, NB; Brown, J; Hosking, D et al.

2001 • In Journal of Bone and Mineral Research, 16 (S1), p. 217

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/124431

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Sustained fracture risk reduction over 5 years with risedronate therapy.pdf

Publisher postprint (274.24 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

General & internal medicine

Author, co-author :

Watts, NB

Brown, J

Hosking, D

Adami, S

Mulder, H

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Kasibhatla, C

Chines, A

Language :

English

Title :

Sustained fracture risk reduction over 5 years with risedronate therapy

Publication date :

2001

Event name :

23rd Annual Meeting of the ASBMR

Event place :

Phoenix, Arizona, United States

Event date :

Du 12 au 16 octobre 2001

Audience :

International

Journal title :

Journal of Bone and Mineral Research

ISSN :

0884-0431

eISSN :

1523-4681

Publisher :

American Society for Bone and Mineral Research, Washington, United States - District of Columbia

Volume :

Issue :

Pages :

217

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 06 June 2012

Statistics

Number of views

22 (1 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics